Healthcare IT Today September 9, 2021
Healthcare IT News

Neuroglee Therapeutics (‘Neuroglee’), which builds personalized evidence-based digital therapeutics (DTx) and virtual care solutions to treat and manage patients with neurodegenerative diseases, announced today that it has closed a $10 million Series A funding round. The funding injection will enable Neuroglee to launch first-of-their-kind virtual neurology clinics for patients diagnosed with mild cognitive impairment related to difficult-to-treat conditions such as Alzheimer’s disease, while also advancing the company’s DTx pipeline.

Openspace Ventures and EDBI led the round. Additional capital has come from existing investors who have built transformational healthcare businesses, including Raman Singh, ex-CEO of Mundipharma, Biofourmis co-founders Kuldeep Singh Rajput and Wendou Niu, and a leading pharmaceutical company, Eisai Co., which is a strategic shareholder in the company.

“Neuroglee’s solution...

Today's Sponsors

ZeOmega
Holon
Transcarent

Today's Sponsors

Crossover Health
Qure4u

Today's Sponsor

Institute for Healthcare Improvement

 
Topics: Digital Health, Health IT, Investments, Technology, Telehealth, Trends
Evidence That Telehealth Benefits Addiction Treatment is Thin says APA Study
Region, race, and age linked with likelihood of cancer patients using telehealth services
Report: Most Medicare beneficiaries receive telehealth services from providers they know
Oak Street Health Acquires Telehealth Company RubiconMD for $130 Million
FCC awards $40M more in telehealth funding to 71 providers